Ken Griffin’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.4M | Sell |
1,169,682
-739,648
| -39% | -$39.5M | 0.01% | 450 |
|
|
2025
Q1 | $77.3M | Buy |
1,909,330
+554,437
| +41% | +$22.4M | 0.01% | 329 |
|
|
2024
Q4 | $37.7M | Buy |
1,354,893
+1,204,992
| +804% | +$33.5M | 0.01% | 653 |
|
|
2024
Q3 | $4.3M | Sell |
149,901
-245,216
| -62% | -$7.04M | ﹤0.01% | 1893 |
|
|
2024
Q2 | $9.27M | Sell |
395,117
-24,543
| -6% | -$576K | ﹤0.01% | 1252 |
|
|
2024
Q1 | $10.6M | Sell |
419,660
-65,365
| -13% | -$1.65M | ﹤0.01% | 1260 |
|
|
2023
Q4 | $11.3M | Buy |
485,025
+182,438
| +60% | +$4.26M | ﹤0.01% | 1147 |
|
|
2023
Q3 | $15.3M | Sell |
302,587
-23,305
| -7% | -$1.18M | ﹤0.01% | 923 |
|
|
2023
Q2 | $15.2M | Sell |
325,892
-529,816
| -62% | -$24.7M | ﹤0.01% | 950 |
|
|
2023
Q1 | $32.7M | Buy |
855,708
+593,991
| +227% | +$22.7M | 0.01% | 618 |
|
|
2022
Q4 | $14.3M | Buy |
261,717
+84,556
| +48% | +$4.63M | ﹤0.01% | 1067 |
|
|
2022
Q3 | $6.03M | Buy |
177,161
+78,551
| +80% | +$2.67M | ﹤0.01% | 1689 |
|
|
2022
Q2 | $932K | Buy |
98,610
+10,800
| +12% | +$102K | ﹤0.01% | 3485 |
|
|
2022
Q1 | $1.25M | Buy |
87,810
+60,371
| +220% | +$857K | ﹤0.01% | 3533 |
|
|
2021
Q4 | $580K | Sell |
27,439
-5,430
| -17% | -$115K | ﹤0.01% | 4432 |
|
|
2021
Q3 | $735K | Sell |
32,869
-25,193
| -43% | -$563K | ﹤0.01% | 4125 |
|
|
2021
Q2 | $1.44M | Sell |
58,062
-82,813
| -59% | -$2.05M | ﹤0.01% | 3600 |
|
|
2021
Q1 | $4.09M | Sell |
140,875
-74,829
| -35% | -$2.17M | ﹤0.01% | 2340 |
|
|
2020
Q4 | $5.57M | Buy |
215,704
+175,013
| +430% | +$4.52M | ﹤0.01% | 1688 |
|
|
2020
Q3 | $1.25M | Sell |
40,691
-16,924
| -29% | -$521K | ﹤0.01% | 2722 |
|
|
2020
Q2 | $1.44M | Buy |
+57,615
| New | +$1.44M | ﹤0.01% | 2533 |
|
|
2020
Q1 | – | Sell |
-20,702
| Closed | -$459K | – | 4807 |
|
|
2019
Q4 | $459K | Sell |
20,702
-2,517
| -11% | -$55.8K | ﹤0.01% | 3603 |
|
|
2019
Q3 | $528K | Buy |
+23,219
| New | +$528K | ﹤0.01% | 3429 |
|